|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Loss | |||||
| Depreciation and amortization | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Warrants issued for underwriting fee | |||||
| Allowance for doubtful accounts | |||||
| Impairment of capitalized software | |||||
| Forfeiture of accrued director compensation | |||||
| Changes in operating assets and liabilities which used cash: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Deferred revenue | |||||
| Other accrued liabilities | |||||
| Net cash and cash equivalents used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchase of property and equipment | |||||
| Investment in capitalized software | |||||
| Net cash and cash equivalents used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Net cash and cash equivalents provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash - Beginning of year | |||||
| Cash, cash equivalents, and restricted cash - End of year | |||||
| SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES: | |||||
| Settle restricted stock units through common stock issuance to directors | |||||
| Issuance of common stock for accrued director compensation | |||||
| Issuance of common stock for public offering consulting expenses | |||||
| RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TO THE BALANCE SHEET: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, non-current | |||||
Loading...
